APA (7th ed.) Citation

Yu, J., Zhou, Z., Tay-Sontheimer, J., Levy, R. H., & Ragueneau-Majlessi, I. (2018). Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016. Drug metabolism and disposition, 46(6), 835-845. https://doi.org/10.1124/dmd.117.078691

Chicago Style (17th ed.) Citation

Yu, Jingjing, Zhu Zhou, Jessica Tay-Sontheimer, René H. Levy, and Isabelle Ragueneau-Majlessi. "Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016." Drug Metabolism and Disposition 46, no. 6 (2018): 835-845. https://doi.org/10.1124/dmd.117.078691.

MLA (9th ed.) Citation

Yu, Jingjing, et al. "Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016." Drug Metabolism and Disposition, vol. 46, no. 6, 2018, pp. 835-845, https://doi.org/10.1124/dmd.117.078691.